BNP Paribas Financial Markets
TLSA icon

BNP Paribas Financial Markets’s Tiziana Life Sciences TLSA Stock Holding History

BNP Paribas Financial Markets’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,933
Closed -$2.09K – 5666
2025
Q1 		$2.09K Sell
1,933
-7,367
-79% -$7.2K ﹤0.01% 4980
2024
Q4 		$6.47K Buy
+9,300
New +$8.6K ﹤0.01% 4899

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

BNP Paribas Financial Markets's TLSA Position: Q2 2025 in Review

BNP Paribas Financial Markets sold out of Tiziana Life Sciences (TLSA) in Q2 2025, closing a stake of 1,933 shares — an estimated $2.09K sold.

BNP Paribas Financial Markets first reported a position in TLSA in Q4 2024 and held it in 2 quarters. The position peaked at $6.47K in Q4 2024. 30 funds tracked by Wall St. Rank hold TLSA as of Q2 2025.

  • BNP Paribas Financial Markets reported no remaining Tiziana Life Sciences position as of Q2 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1,933 Tiziana Life Sciences shares in Q2 2025, an estimated $2.09K.
  • BNP Paribas Financial Markets first reported a position in Tiziana Life Sciences in Q4 2024 and held it in 2 quarters.
  • BNP Paribas Financial Markets's Tiziana Life Sciences position peaked at $6.47K in Q4 2024.
  • 30 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2025, filed 14 Aug 2025.